Subject(s)

Betacoronavirus/immunology , Coronavirus Infections/prevention & control , Drug Development , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Viral Vaccines , Antibodies, Neutralizing/immunology , COVID-19 , COVID-19 Vaccines , Coronavirus Infections/immunology , Intersectoral Collaboration , RNA, Messenger/administration & dosage , RNA, Messenger/adverse effects , RNA, Messenger/immunology , SARS-CoV-2 , Spike Glycoprotein, Coronavirus/genetics , Spike Glycoprotein, Coronavirus/immunology , T-Lymphocytes/immunology , Vaccines, DNA/administration & dosage , Vaccines, DNA/adverse effects , Vaccines, DNA/immunology , Viral Vaccines/administration & dosage , Viral Vaccines/adverse effects , Viral Vaccines/immunology